Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Added keyword: B-cell chronic lymphocytic leukemia to the study page. This change does not affect core content or study parameters.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded 'Results Posted' and new site details including Bergamo, Italy. Expanded Dose Escalation and Dose Expansion sections with detailed study endpoint definitions (PFS, TTR, DOR, ORR, CBR) and scheduling; removed older endpoint descriptions and some prior location text.SummaryDifference5%

- Check66 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1. This appears to be a minor site maintenance update and does not alter the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.